Knee News and Research

RSS

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.

10 Feb 2014

New prosthetic devices allow people to function more effectively in daily activities

Thanks to advanced technologies, those who wear prosthetic and orthotic devices are now able to break previous activity boundaries. People with amputations now have prosthetic devices that allow them to engage in and function more effectively in a wider range of daily activities, exercise, sports, and even extreme sports, such as long-distance snowshoeing and ice climbing.

9 Feb 2014

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2013. The Company reported fourth quarter net sales of $1.24 billion, an increase of 5.1% reported and 6.6% constant currency over the fourth quarter of 2012.

30 Jan 2014

Tufts Medical Center receives funds to develop mathematical models to identify patients for clinical trials

A Tufts Medical Center research team at the Institute for Clinical Research and Health Policy Studies (ICRHPS) has been approved for a funding award by the Patient-Centered Outcomes Research Institute (PCORI) to develop a method for patient-centered enrollment in comparative effectiveness trials called Mathematical Equipoise.

28 Jan 2014

Viewpoints: Target has the right idea for part-timers; health law 'beyond rescue;' fighting back to secure the right to abortion

The big noise on the health insurance front today was sounded by Target, which announced via a corporate blog that it's ending health insurance for its part-time workers. Instead of signing up for a company plan, they're encouraged to use the health care exchanges set up through the Affordable Care Act. ...

24 Jan 2014

Researchers trace origins of humans' locomotory habits

Humans and some of our hominid ancestors such as Homo erectus have been walking for more than a million years, and researchers are close to figuring out how we do it.

20 Jan 2014

FDA approves New Drug Application for PENNSA 2%

Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).

17 Jan 2014

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

A single stem cell injection following meniscus knee surgery may provide pain relief and aid in meniscus regrowth, according to a novel study appearing in the January issue of the Journal of Bone and Joint Surgery (JBJS).

17 Jan 2014

Researchers use silver nanowires to develop sensors for prosthetics, robotic systems

North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible touch panels.

16 Jan 2014

Researchers develop "smart" hydrogel that can deliver medicine on demand

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

16 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Viewpoints: 'Celebrating' enrollment numbers; Maryland's website 'debacle;' abortion battle moves again to high court

Today the federal government released the most comprehensive data yet about who signed up for Obamacare through Dec. 28. There's reason to cheer for both the law's supporters and its detractors. ... Today's numbers don't settle the question of whether the administration will hit its goals for enrollment in the exchanges, measured either in raw numbers or demographic breakdown. But they show that those goals are within reach (Christopher Flavelle, 1/13).

15 Jan 2014

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.

10 Jan 2014

UPC researchers conduct biomechanical study of footwear made by Camper

Researchers from the Polytechnic University of Catalonia (UPC) have carried out a biomechanical study of the footwear made by Camper. A group of 54 volunteers took part in the project, trying on six models of men's shoes and six models of women's shoes.

8 Jan 2014

Surgeon highlights factors that can prevent revision surgery after hip or knee replacement

Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.

2 Jan 2014

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

The Finnish Degenerative Meniscal Lesion Study (FIDELITY) compared surgical treatment of degenerative meniscal tears to placebo surgery.

27 Dec 2013

Surgeons at French hospital perform first Navio UKR procedures

Blue Belt Technologies announces the first Navio™ unicondylar knee replacement (UKR) procedures performed in France, completed on September 30th, October 15th and Nov 4th 2013 by Professor Philippe Neyret and Dr. Sébastien Lustig at Hospices Civils de Lyon in France.

23 Dec 2013

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.

19 Dec 2013

Osteoarthritis patients can carry out progressive exercise to maintain bone health

The postmenopausal women who may be at risk of osteoporosis (bone loss), as well as at risk of osteoarthritis, can safely carry out progressive high-impact training to maintain bone health and physical function.